false
0001527613
0001527613
2026-05-12
2026-05-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 12, 2026
CIMG
Inc.
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-39338 |
|
38-3849791 |
(State
or other jurisdiction
of
incorporation or organization |
|
(Commission
File
No.) |
|
(IRS
Employer
Identification
No.) |
Room
R2, FTY D, 16/F, Kin
Ga Industrial Building,
9
San On Street, Tuen
Mun, Hong
Kong 0000
(Address
of principal executive offices)
+
852 70106695
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.00001 par value |
|
IMG |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02 Results of Operations and Financial Condition
On
May 13, 2026, CIMG Inc. issued a press release (the “Press Release”) announcing its financial results for the three months
ended March 31, 2026. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The
Press Release contains certain business updates and forward-looking statements regarding the Company’s expectations, plans and
prospects. The information in this Item 2.02 and Exhibit 99.1 hereto is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 99.1 |
|
The Press Release |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
| |
CIMG
Inc. |
| |
|
|
| Dated:
May 13, 2026 |
By: |
/s/
Jianshuang
Wang |
| |
Name: |
Jianshuang
Wang |
| |
Title: |
Chief
Executive Officer |
Exhibit
99.1
CIMG
Inc. Reports Q2 2026 Financial Results
HONG
KONG, May 13, 2026 /PRNewswire/ — CIMG Inc. (“CIMG” or the “Company”) (Nasdaq: IMG; OTCID: CIMG),
a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance
its business partners’ sales growth and commercial value, today announced its financial results for the quarterly period ended
March 31, 2026. During the reporting period, the Company achieved rapid revenue growth, expanded its channel presence in the Asian market,
and initially formed a synergistic development pattern between digital assets and new businesses.
Total
revenue for the quarter ended March 31, 2026 reached $3.2 million, representing substantial growth compared with the same period last
year.
Total
revenue for the six months ended March 31, 2026 amounted to $18.9 million, surging 82,969% year over year, with all three core product
lines delivering strong performance.
The
Company’s total assets stood at approximately $53.18 million, including 730 bitcoins with an aggregate carrying value of $49.85
million as of March 31, 2026, reflecting the significance of the Company’s digital asset holdings.
The
Company maintains a diversified business structure consisting of three segments, enhancing its risk resilience:
●
The Maca Products Series: Launched blockbuster products, including Maca-Noni and Maca Coffee.
●
The Homology of Medicine and Food Series: Centered on Huomao products, exosomes and other product lines, aligning with current health
consumption trends.
●
The Computing Power Products: AI computing modules and GPU hardware sales have been launched, serving multiple commercial bank clients
and expanding the Company’s B2B business scope.
Since
2025, the Company has been undergoing a strategic transformation and is now focusing on the Asian market. It has completed multiple mergers,
acquisitions and business integrations, establishing a full-coverage, omnichannel sales network.
Alice
Wang, Chairman and CEO of CIMG, stated: “The revenue structure continued to improve during the quarter ended March 31, 2026, with
steady improvements in supply chain and channel efficiency. Meanwhile, the Company is actively advancing financing initiatives to optimize
cash flow. We are confident in achieving a breakthrough in profitability in the near term through business growth and asset operations.”
“This
quarter also marks a critical juncture in the Company’s strategic transformation. By focusing on the dual tracks of comprehensive
health and AI computing power, the Company is transforming its business while further expanding revenue. Despite challenges from the
overall market conditions, strong demand in the Asia market, a well-established product portfolio, and digital asset holdings may support
the Company’s long-term strategic initiatives,” Alice Wang added.
About
CIMG
CIMG
is a business group specializing in digital health and sales development, with a cryptocurrency-focused strategy. The Company leverages
AI and cryptocurrencies (such as Bitcoin and stablecoins) to drive business growth, helping clients maximize
user growth and enhance brand management value. The Company’s current client portfolio includes brands such as Kangduoyuan, Maca-Noni,
Qianmao, Huomao, and Coco-mango.
Forward-Looking
Statements
This
press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “aim,”
“intend,” “plan,” “believe,” “estimate,” “expect,” “project,”
“target,” “may,” “should,” “will,” “future,” “likely,” and similar
references to future periods. These forward-looking statements include, without limitation, statements regarding the Company’s
expected operating results, revenue growth, business strategy, development of its AI computing and digital health businesses, digital
asset strategy, potential future purchases or holdings of Bitcoin or other digital assets, anticipated benefits from computing power
service contracts, liquidity and capital resources, and the Company’s ability to execute its strategic plans.
Forward-looking
statements are based on current expectations and assumptions that are subject to risks and uncertainties, including, but not limited
to, risks related to fluctuations in the market price of Bitcoin and other digital assets; the Company’s ability to execute and
realize the expected benefits of computing power and digital health contracts; the Company’s ability to raise additional capital
if needed; its ability to maintain compliance with Nasdaq listing standards; risks related to doing business in the People’s Republic
of China, including regulatory, legal, and currency transfer risks; general economic and market conditions; competition; and other risks
described in the Company’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on
Form 10-K and subsequent filings.
Actual
results may differ materially from those expressed or implied by these forward-looking statements. The Company undertakes no obligation
to update or revise any forward-looking statements contained herein, except as required by applicable law.
For
more information, please contact:
CIMG
Inc.
+
852 70106695
http://www.ccmg.tech
ir@ccmg.tech
